The global baby food market size is expected to reach around US$ 120 billion by 2030 and is expected to grow at an impressive double-digit rate of 5.54% from 2022 to 2030.
The study includes drivers and restraints of this market. The study provides an analysis of the global baby food market for the period 2017-2030, wherein 2022 to 2030 is the forecast period and 2021 is considered as the base year.
Report Scope of the Baby Food Market
| Report Coverage | Details |
| Market Size by 2030 | USD 120 Billion |
| Growth Rate from 2022 to 2030 | CAGR of 5.54% |
| Largest Market | Asia Pacific |
| Online Distribution Channel Segment Growth Rate | 13.2% from 2022 to 2030 |
| Base Year | 2021 |
| Forecast Period | 2022 to 2030 |
Our Free Sample Reports Includes:
- In-depth Industry Analysis, Introduction, Overview, and COVID-19 Pandemic Outbreak.
- Impact Analysis 150+ Pages Research Report (Including latest research).
- Provide chapter-wise guidance on request 2022 Updated Regional Analysis with Graphical Representation of Trends, Size, & Share, Includes Updated List of figures and tables.
- Updated Report Includes Major Market Players with their Sales Volume, Business Strategy and Revenue Analysis by using Precedence Research methodology.
Download Free Sample Copy Here (Including TOC, List of Tables & Figures, and Chart) @ https://www.precedenceresearch.com/sample/1710
Research Methodology
A unique research methodology has been utilized to conduct comprehensive research on the growth of the global baby food market and arrive at conclusions on the future growth prospects of the market. This research methodology is a combination of primary and secondary research, which helps analysts warrant the accuracy and reliability of the draw conclusions. Secondary sources referred to by analysts during the production of the global market report include statistics from company annual reports, SEC filings, company websites, World Bank database, investor presentations, regulatory databases, government publications, and industry white papers. Analysts have also interviewed senior managers, product portfolio managers, CEOs, VPs, and market intelligence managers, who contributed to the production of our study on the market as a primary source.
These primary and secondary sources provided exclusive information during interviews, which serves as a validation from mattress topper industry leaders. Access to an extensive internal repository and external proprietary databases allows this report to address specific details and questions about the global baby food market with accuracy. The study also uses the top-down approach to assess the numbers for each segment and the bottom-up approach to counter-validate them. This has helped to estimates the future prospects of the global market more reliable and accurate.
Why should you invest in this report?
If you are aiming to enter the global baby food market, this report is a comprehensive guide that provides crystal clear insights into this niche market. All the major application areas for baby food are covered in this report and information is given on the important regions of the world where this market is likely to boom during the forecast period of 2022-2030, so that you can plan your strategies to enter this market accordingly.
Besides, through this report, you can have a complete grasp of the level of competition you will be facing in this hugely competitive market and if you are an established player in this market already, this report will help you gauge the strategies that your competitors have adopted to stay as market leaders in this market. For new entrants to this market, the voluminous data provided in this report is invaluable.
Some of the prominent players in the global baby food market include:
- Nestlé (Gerber Products Company)
- Danone S.A.
- Reckitt Benckiser (Mead Johnson & Company, LLC)
- Abbott
- Feihe International Inc.
- Fries land Campina
- Bellamy's Organic
- Kraft Heinz
- HiPP GmbH & Co. Vertrieb KG
- Perrigo
- Arla Food
Market Segmentation:
By Category
- Organic
- Conventional
By Types
- Milk Formula
- Dried
- Ready-to-Feed
- Other
By Distribution Channel
- Drugstores/ Pharmacies
- Supermarkets/Hypermarkets
- Convenience Store
- Online Channels
- Other Distribution Channels
By Ingredients
- Fats and Oils
- Lactose
- Protein
- Flour
- Flavour Enhancer
- Vitamins & Minerals
- Others
By Formulation
- Powder
- Liquid
By Health Benefit
- Brain & Eye Development
- Muscular Growth
- Bones & Teeth Development
- Blood Enhancement
- Nervous System
- Vascular System
- Body Energy
- Other
Regional Analysis:
The geographical analysis of the global baby food market has been done for North America, Europe, Asia-Pacific, and the Rest of the World.
The North American Market is again segmented into the US, Canada, and Mexico. Coming to the European Market, it can be segmented further into the UK, Germany, France, Italy, Spain, and the rest. Coming to the Asia-Pacific, the global baby food Market is segmented into China, India, Japan, and Rest of Asia Pacific. Among others, the market is segmented into the Middle East and Africa, (GCC, North Africa, South Africa and Rest of the Middle East & Africa).
Key Questions Answered by the Report:
- What will be the size of the global baby food market in 2030?
- What is the expected CAGR for the baby food market between 2021 and 2030?
- Which are the top players active in this global market?
- What are the key drivers of this global market?
- How will the market situation change in the coming years?
- Which region held the highest market share in this global market?
- What are the common business tactics adopted by players?
- What is the growth outlook of the global baby food market?
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Health Benefit Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Baby Food Market
5.1. COVID-19 Landscape: Baby Food Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Baby Food Market, By Category Type
8.1. Baby Food Market, by Category Type, 2022-2030
8.1.1. Organic
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Conventional
8.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global Baby Food Market, By Types
9.1. Baby Food Market, by Types Type, 2022-2030
9.1.1. Milk Formula
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. Dried
9.1.2.1. Market Revenue and Forecast (2017-2030)
9.1.3. Ready-to-Feed
9.1.3.1. Market Revenue and Forecast (2017-2030)
9.1.4. Others
9.1.4.1. Market Revenue and Forecast (2017-2030)
Chapter 10. Global Baby Food Market, By Ingredients Type
10.1. Baby Food Market, by Ingredients Type, 2022-2030
10.1.1. Fats and Oils
10.1.1.1. Market Revenue and Forecast (2017-2030)
10.1.2. Lactose
10.1.2.1. Market Revenue and Forecast (2017-2030)
10.1.3. Protein
10.1.3.1. Market Revenue and Forecast (2017-2030)
10.1.4. Flour
10.1.4.1. Market Revenue and Forecast (2017-2030)
10.1.5. Flavour Enhancer
10.1.5.1. Market Revenue and Forecast (2017-2030)
10.1.6. Vitamins & Minerals
10.1.6.1. Market Revenue and Forecast (2017-2030)
10.1.7. Others
10.1.7.1. Market Revenue and Forecast (2017-2030)
Chapter 11. Global Baby Food Market, By Formulation Type
11.1. Baby Food Market, by Formulation Type, 2022-2030
11.1.1. Powder
11.1.1.1. Market Revenue and Forecast (2017-2030)
11.1.2. Liquid
11.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 12. Global Baby Food Market, By Distribution Channel
12.1. Baby Food Market, by Distribution Channel, 2022-2030
12.1.1. Drugstores/ Pharmacies
12.1.1.1. Market Revenue and Forecast (2017-2030)
12.1.2. Supermarkets/Hypermarkets
12.1.2.1. Market Revenue and Forecast (2017-2030)
12.1.3. Online Channels
12.1.3.1. Market Revenue and Forecast (2017-2030)
12.1.4. Convenience Store
12.1.4.1. Market Revenue and Forecast (2017-2030)
12.1.5. Others
12.1.5.1. Market Revenue and Forecast (2017-2030)
Chapter 13. Global Baby Food Market, By Health Benefit
13.1. Baby Food Market, by Health Benefit Type, 2022-2030
13.1.1. Brain & Eye Development
13.1.1.1. Market Revenue and Forecast (2017-2030)
13.1.2. Muscular Growth
13.1.2.1. Market Revenue and Forecast (2017-2030)
13.1.3. Bones & Teeth Development
13.1.3.1. Market Revenue and Forecast (2017-2030)
13.1.4. Blood Enhancement
13.1.4.1. Market Revenue and Forecast (2017-2030)
13.1.5. Nervous System
13.1.5.1. Market Revenue and Forecast (2017-2030)
13.1.6. Vascular System
13.1.6.1. Market Revenue and Forecast (2017-2030)
13.1.7. Body Energy
13.1.7.1. Market Revenue and Forecast (2017-2030)
13.1.8. Others
13.1.8.1. Market Revenue and Forecast (2017-2030)
Chapter 14. Global Baby Food Market, Regional Estimates and Trend Forecast
14.1. North America
14.1.1. Market Revenue and Forecast, by Category (2017-2030)
14.1.2. Market Revenue and Forecast, by Types (2017-2030)
14.1.3. Market Revenue and Forecast, by Ingredients (2017-2030)
14.1.4. Market Revenue and Forecast, by Formulation (2017-2030)
14.1.5. Market Revenue and Forecast, by Distribution Channel (2017-2030)
14.1.6. Market Revenue and Forecast, by Health Benefit (2017-2030)
14.1.7. U.S.
14.1.7.1. Market Revenue and Forecast, by Category (2017-2030)
14.1.7.2. Market Revenue and Forecast, by Types (2017-2030)
14.1.7.3. Market Revenue and Forecast, by Ingredients (2017-2030)
14.1.7.4. Market Revenue and Forecast, by Formulation (2017-2030)
14.1.8. Market Revenue and Forecast, by Distribution Channel (2017-2030)
14.1.8.1. Market Revenue and Forecast, by Health Benefit (2017-2030)
14.1.9. Rest of North America
14.1.9.1. Market Revenue and Forecast, by Category (2017-2030)
14.1.9.2. Market Revenue and Forecast, by Types (2017-2030)
14.1.9.3. Market Revenue and Forecast, by Ingredients (2017-2030)
14.1.9.4. Market Revenue and Forecast, by Formulation (2017-2030)
14.1.10. Market Revenue and Forecast, by Distribution Channel (2017-2030)
14.1.11. Market Revenue and Forecast, by Health Benefit (2017-2030)
14.1.11.1.
14.2. Europe
14.2.1. Market Revenue and Forecast, by Category (2017-2030)
14.2.2. Market Revenue and Forecast, by Types (2017-2030)
14.2.3. Market Revenue and Forecast, by Ingredients (2017-2030)
14.2.4. Market Revenue and Forecast, by Formulation (2017-2030)
14.2.5. Market Revenue and Forecast, by Distribution Channel (2017-2030)
14.2.6. Market Revenue and Forecast, by Health Benefit (2017-2030)
14.2.7.
14.2.8. UK
14.2.8.1. Market Revenue and Forecast, by Category (2017-2030)
14.2.8.2. Market Revenue and Forecast, by Types (2017-2030)
14.2.8.3. Market Revenue and Forecast, by Ingredients (2017-2030)
14.2.9. Market Revenue and Forecast, by Formulation (2017-2030)
14.2.10. Market Revenue and Forecast, by Distribution Channel (2017-2030)
14.2.10.1. Market Revenue and Forecast, by Health Benefit (2017-2030)
14.2.11. Germany
14.2.11.1. Market Revenue and Forecast, by Category (2017-2030)
14.2.11.2. Market Revenue and Forecast, by Types (2017-2030)
14.2.11.3. Market Revenue and Forecast, by Ingredients (2017-2030)
14.2.12. Market Revenue and Forecast, by Formulation (2017-2030)
14.2.13. Market Revenue and Forecast, by Distribution Channel (2017-2030)
14.2.14. Market Revenue and Forecast, by Health Benefit (2017-2030)
14.2.14.1.
14.2.15. France
14.2.15.1. Market Revenue and Forecast, by Category (2017-2030)
14.2.15.2. Market Revenue and Forecast, by Types (2017-2030)
14.2.15.3. Market Revenue and Forecast, by Ingredients (2017-2030)
14.2.15.4. Market Revenue and Forecast, by Formulation (2017-2030)
14.2.16. Market Revenue and Forecast, by Distribution Channel (2017-2030)
14.2.16.1. Market Revenue and Forecast, by Health Benefit (2017-2030)
14.2.17. Rest of Europe
14.2.17.1. Market Revenue and Forecast, by Category (2017-2030)
14.2.17.2. Market Revenue and Forecast, by Types (2017-2030)
14.2.17.3. Market Revenue and Forecast, by Ingredients (2017-2030)
14.2.17.4. Market Revenue and Forecast, by Formulation (2017-2030)
14.2.18. Market Revenue and Forecast, by Distribution Channel (2017-2030)
14.2.18.1. Market Revenue and Forecast, by Health Benefit (2017-2030)
14.3. APAC
14.3.1. Market Revenue and Forecast, by Category (2017-2030)
14.3.2. Market Revenue and Forecast, by Types (2017-2030)
14.3.3. Market Revenue and Forecast, by Ingredients (2017-2030)
14.3.4. Market Revenue and Forecast, by Formulation (2017-2030)
14.3.5. Market Revenue and Forecast, by Distribution Channel (2017-2030)
14.3.6. Market Revenue and Forecast, by Health Benefit (2017-2030)
14.3.7. India
14.3.7.1. Market Revenue and Forecast, by Category (2017-2030)
14.3.7.2. Market Revenue and Forecast, by Types (2017-2030)
14.3.7.3. Market Revenue and Forecast, by Ingredients (2017-2030)
14.3.7.4. Market Revenue and Forecast, by Formulation (2017-2030)
14.3.8. Market Revenue and Forecast, by Distribution Channel (2017-2030)
14.3.9. Market Revenue and Forecast, by Health Benefit (2017-2030)
14.3.10. China
14.3.10.1. Market Revenue and Forecast, by Category (2017-2030)
14.3.10.2. Market Revenue and Forecast, by Types (2017-2030)
14.3.10.3. Market Revenue and Forecast, by Ingredients (2017-2030)
14.3.10.4. Market Revenue and Forecast, by Formulation (2017-2030)
14.3.11. Market Revenue and Forecast, by Distribution Channel (2017-2030)
14.3.11.1. Market Revenue and Forecast, by Health Benefit (2017-2030)
14.3.12. Japan
14.3.12.1. Market Revenue and Forecast, by Category (2017-2030)
14.3.12.2. Market Revenue and Forecast, by Types (2017-2030)
14.3.12.3. Market Revenue and Forecast, by Ingredients (2017-2030)
14.3.12.4. Market Revenue and Forecast, by Formulation (2017-2030)
14.3.12.5. Market Revenue and Forecast, by Distribution Channel (2017-2030)
14.3.12.6. Market Revenue and Forecast, by Health Benefit (2017-2030)
14.3.13. Rest of APAC
14.3.13.1. Market Revenue and Forecast, by Category (2017-2030)
14.3.13.2. Market Revenue and Forecast, by Types (2017-2030)
14.3.13.3. Market Revenue and Forecast, by Ingredients (2017-2030)
14.3.13.4. Market Revenue and Forecast, by Formulation (2017-2030)
14.3.13.5. Market Revenue and Forecast, by Distribution Channel (2017-2030)
14.3.13.6. Market Revenue and Forecast, by Health Benefit (2017-2030)
14.4. MEA
14.4.1. Market Revenue and Forecast, by Category (2017-2030)
14.4.2. Market Revenue and Forecast, by Types (2017-2030)
14.4.3. Market Revenue and Forecast, by Ingredients (2017-2030)
14.4.4. Market Revenue and Forecast, by Formulation (2017-2030)
14.4.5. Market Revenue and Forecast, by Distribution Channel (2017-2030)
14.4.6. Market Revenue and Forecast, by Health Benefit (2017-2030)
14.4.7. GCC
14.4.7.1. Market Revenue and Forecast, by Category (2017-2030)
14.4.7.2. Market Revenue and Forecast, by Types (2017-2030)
14.4.7.3. Market Revenue and Forecast, by Ingredients (2017-2030)
14.4.7.4. Market Revenue and Forecast, by Formulation (2017-2030)
14.4.8. Market Revenue and Forecast, by Distribution Channel (2017-2030)
14.4.9. Market Revenue and Forecast, by Health Benefit (2017-2030)
14.4.10. North Africa
14.4.10.1. Market Revenue and Forecast, by Category (2017-2030)
14.4.10.2. Market Revenue and Forecast, by Types (2017-2030)
14.4.10.3. Market Revenue and Forecast, by Ingredients (2017-2030)
14.4.10.4. Market Revenue and Forecast, by Formulation (2017-2030)
14.4.11. Market Revenue and Forecast, by Distribution Channel (2017-2030)
14.4.12. Market Revenue and Forecast, by Health Benefit (2017-2030)
14.4.13. South Africa
14.4.13.1. Market Revenue and Forecast, by Category (2017-2030)
14.4.13.2. Market Revenue and Forecast, by Types (2017-2030)
14.4.13.3. Market Revenue and Forecast, by Ingredients (2017-2030)
14.4.13.4. Market Revenue and Forecast, by Formulation (2017-2030)
14.4.13.5. Market Revenue and Forecast, by Distribution Channel (2017-2030)
14.4.13.6. Market Revenue and Forecast, by Health Benefit (2017-2030)
14.4.14. Rest of MEA
14.4.14.1. Market Revenue and Forecast, by Category (2017-2030)
14.4.14.2. Market Revenue and Forecast, by Types (2017-2030)
14.4.14.3. Market Revenue and Forecast, by Ingredients (2017-2030)
14.4.14.4. Market Revenue and Forecast, by Formulation (2017-2030)
14.4.14.5. Market Revenue and Forecast, by Distribution Channel (2017-2030)
14.4.14.6. Market Revenue and Forecast, by Health Benefit (2017-2030)
14.5. Latin America
14.5.1. Market Revenue and Forecast, by Category (2017-2030)
14.5.2. Market Revenue and Forecast, by Types (2017-2030)
14.5.3. Market Revenue and Forecast, by Ingredients (2017-2030)
14.5.4. Market Revenue and Forecast, by Formulation (2017-2030)
14.5.5. Market Revenue and Forecast, by Distribution Channel (2017-2030)
14.5.6. Market Revenue and Forecast, by Health Benefit (2017-2030)
14.5.7. Brazil
14.5.7.1. Market Revenue and Forecast, by Category (2017-2030)
14.5.7.2. Market Revenue and Forecast, by Types (2017-2030)
14.5.7.3. Market Revenue and Forecast, by Ingredients (2017-2030)
14.5.7.4. Market Revenue and Forecast, by Formulation (2017-2030)
14.5.8. Market Revenue and Forecast, by Distribution Channel (2017-2030)
14.5.8.1. Market Revenue and Forecast, by Health Benefit (2017-2030)
14.5.9. Rest of LATAM
14.5.9.1. Market Revenue and Forecast, by Category (2017-2030)
14.5.9.2. Market Revenue and Forecast, by Types (2017-2030)
14.5.9.3. Market Revenue and Forecast, by Ingredients (2017-2030)
14.5.9.4. Market Revenue and Forecast, by Formulation (2017-2030)
14.5.9.5. Market Revenue and Forecast, by Distribution Channel (2017-2030)
14.5.9.6. Market Revenue and Forecast, by Health Benefit (2017-2030)
Chapter 15. Company Profiles
15.1. Nestlé (Gerber Products Company)
15.1.1. Company Overview
15.1.2. Product Offerings
15.1.3. Financial Performance
15.1.4. Recent Initiatives
15.2. Danone S.A.
15.2.1. Company Overview
15.2.2. Product Offerings
15.2.3. Financial Performance
15.2.4. Recent Initiatives
15.3. Reckitt Benckiser (Mead Johnson & Company, LLC)
15.3.1. Company Overview
15.3.2. Product Offerings
15.3.3. Financial Performance
15.3.4. Recent Initiatives
15.4. Abbott
15.4.1. Company Overview
15.4.2. Product Offerings
15.4.3. Financial Performance
15.4.4. Recent Initiatives
15.5. Feihe International Inc.
15.5.1. Company Overview
15.5.2. Product Offerings
15.5.3. Financial Performance
15.5.4. Recent Initiatives
15.6. Fries land Campina
15.6.1. Company Overview
15.6.2. Product Offerings
15.6.3. Financial Performance
15.6.4. Recent Initiatives
15.7. Bellamy's Organic
15.7.1. Company Overview
15.7.2. Product Offerings
15.7.3. Financial Performance
15.7.4. Recent Initiatives
15.8. Kraft Heinz
15.8.1. Company Overview
15.8.2. Product Offerings
15.8.3. Financial Performance
15.8.4. Recent Initiatives
15.9. HiPP GmbH & Co. Vertrieb KG
15.9.1. Company Overview
15.9.2. Product Offerings
15.9.3. Financial Performance
15.9.4. Recent Initiatives
15.10. Perrigo
15.10.1. Company Overview
15.10.2. Product Offerings
15.10.3. Financial Performance
15.10.4. Recent Initiatives
15.11. Arla Food
15.11.1. Company Overview
15.11.2. Product Offerings
15.11.3. Financial Performance
15.11.4. Recent Initiatives
Chapter 16. Research Methodology
16.1. Primary Research
16.2. Secondary Research
16.3. Assumptions
Chapter 17. Appendix
17.1. About Us
17.2. Glossary of Terms
Contact Us:
Mr. Alex
Sales Manager
Call: +1 9197 992 333
Email: sales@precedenceresearch.com
0 Comments